Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NSE - Free Realtime Quote INR

Indoco Remedies Limited (INDOCO.NS)

Compare
236.97
+3.37
+(1.44%)
As of 1:11:00 PM GMT+5:30. Market Open.
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
16,964,755
17,882,155
16,400,480
15,037,374
12,186,078
Cost of Revenue
5,559,950
5,820,950
5,393,136
4,795,998
3,701,289
Gross Profit
11,404,805
12,061,205
11,007,344
10,241,376
8,484,789
Operating Expense
11,124,396
10,632,596
9,030,955
8,039,114
6,893,481
Operating Income
280,409
1,428,609
1,976,389
2,202,262
1,591,308
Net Non Operating Interest Income Expense
-573,305
-350,505
-246,918
-169,576
-213,111
Pretax Income
41,285
1,357,985
1,927,921
2,365,712
1,319,971
Tax Provision
187,147
387,947
505,406
817,717
389,516
Net Income Common Stockholders
-106,599
984,601
1,422,515
1,547,995
930,455
Diluted NI Available to Com Stockholders
-106,599
984,601
1,422,515
1,547,995
930,455
Basic EPS
-1.58
10.53
15.44
16.80
10.10
Diluted EPS
-1.59
10.51
15.42
16.80
10.10
Basic Average Shares
85,341.74
92,150.62
92,150.36
92,150.36
92,124.26
Diluted Average Shares
85,341.74
92,150.62
92,150.36
92,150.36
92,150.36
Rent Expense Supplemental
--
82,286
74,384
56,708
49,998
Total Expenses
16,684,346
16,453,546
14,424,091
12,835,112
10,594,770
Net Income from Continuing & Discontinued Operation
-106,599
984,601
1,422,515
1,547,995
930,455
Normalized Income
-193,933.80
961,125.54
1,432,183.04
1,571,946.69
1,048,690.23
Interest Income
--
39,551
5,809
4,738
7,885
Interest Expense
593,592
370,792
237,503
164,579
210,413
Net Interest Income
-573,305
-350,505
-246,918
-169,576
-213,111
EBIT
634,877
1,728,777
2,165,424
2,530,291
1,530,384
EBITDA
1,747,730
2,647,430
2,871,486
3,302,380
2,261,635
Reconciled Cost of Revenue
5,559,950
5,820,950
5,393,136
4,795,998
3,701,289
Reconciled Depreciation
1,112,853
918,653
706,062
772,042
731,251
Net Income from Continuing Operation Net Minority Interest
-106,599
984,601
1,422,515
1,547,995
930,455
Total Unusual Items Excluding Goodwill
124,764
32,864
-13,103
-36,604
-167,732
Total Unusual Items
124,764
32,864
-13,103
-36,604
-167,732
Normalized EBITDA
1,622,966
2,614,566
2,884,589
3,338,984
2,429,367
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
37,429.20
9,388.54
-3,434.96
-12,652.31
-49,496.77
3/31/2021 - 1/14/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GODAVARI.BO Godavari Drugs Limited
92.45
+0.39%
 
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,448.95
+0.53%
 
IPCALAB.BO Ipca Laboratories Limited
1,357.40
+4.34%
 
ALKEM.BO Alkem Laboratories Limited
4,840.70
+2.99%
 
NOVARTIND.BO Novartis India Limited
795.05
+1.13%
 
BALPHARMA.BO Bal Pharma Limited
112.75
+2.80%
 
ERIS.NS Eris Lifesciences Limited
1,328.80
+4.25%
 
GUFICBIO.NS Gufic Biosciences Limited
318.40
+2.70%
 
BAJAJHCARE.NS Bajaj HealthCare Limited
584.00
+2.58%
 
LUPIN.BO Lupin Limited
1,979.00
+2.92%